Kalytera Therapeutics is a biotechnological company that is involved in developing cannabinoid therapeutics. Kalyterainc was founded in 2016. Kalyterainc's headquarters is located in Novato, California, USA 94949. It has raised 200.0K in 1 round. The ...
Kalyterainc's President & CEO, Robert Farrell, currently has an approval
rating of 70%. Kalyterainc's primary competitors are
There are no competitors identified for Kalyterainc
There have been no acquisitions found related to Kalyterainc
Recent investment data cannot be found related to Kalyterainc